PrEP is prevention selected with a care team
PrEP is used by people without HIV before possible exposure. Being “on PrEP” is not the name of a separately approved medicine. Product choice depends on health, exposure route, preferences and local availability; this article is not a worldwide approval catalogue. [1]
PrEP can be highly effective when used as prescribed, but protection is not an all-route, all-product percentage or a guarantee. Injectable options still require timely visits and testing; they do not remove every adherence barrier. [1]
Assessment and testing come before choosing a plan
Testing must account for the most recent exposure, symptoms and any recent PrEP or PEP. An early negative result may not exclude the latest exposure. Starting PrEP during unrecognized HIV can select resistance; that does not mean future HIV treatment is impossible. [1] [2]
Kidney, hepatitis and STI assessments and subsequent monitoring depend on the product and person. Tell the team about medicines and practical access needs. Do not stop or restart medication, including in the context of hepatitis B, without advice. [1]
Do not copy daily or event-driven pill instructions
Daily and event-driven approaches are not interchangeable for every person, product or exposure. Event-driven use requires an individual assessment and is unsuitable in some circumstances. This article intentionally does not provide a pill-count schedule or instructions for self-prescribing. [1]
Follow-up is not universally every three months. Agree a plan for HIV testing, monitoring, missed doses or visits and stopping or restarting with the service that prescribes your medicine. [1]
A recent possible exposure may need PEP instead
Seek PEP assessment as soon as possible and start when indicated within 72 hours. Do not wait for symptoms, all pending laboratory results or an online booking. Even after that window, seek assessment and a testing plan. Do not substitute or share PrEP yourself. [3]
Prevention choices do not determine moral worth
Do not infer the need for PrEP from identity, occupation or partner count alone. Discuss actual circumstances and preferences without stereotyping. U=U means a person on ART who maintains suppression meeting clinical criteria does not transmit HIV through sex; it is not a cure or a guarantee for breastfeeding or sharing injection equipment. [1] [4] [5]
PrEP does not prevent other STIs or pregnancy. Condoms and suitable lubricant have other roles, but do not provide absolute protection against every STI. Use sterile injection equipment rather than relying on PrEP as an all-purpose substitute. [1] [6] [7]
Ask a provider about available products, eligibility, cost and records. Neither an illustration of pills nor a general article identifies your prescription or establishes that a service is free, anonymous or available locally.
Frequently asked questions
PrEP is prevention selected with a care team
PrEP is used by people without HIV before possible exposure. Being “on PrEP” is not the name of a separately approved medicine. Product choice depends on health, exposure route, preferences and local availability; this article is not a worldwide approval catalogue. [1]
Assessment and testing come before choosing a plan
Testing must account for the most recent exposure, symptoms and any recent PrEP or PEP. An early negative result may not exclude the latest exposure. Starting PrEP during unrecognized HIV can select resistance; that does not mean future HIV treatment is impossible. [1] [2]
Do not copy daily or event-driven pill instructions
Daily and event-driven approaches are not interchangeable for every person, product or exposure. Event-driven use requires an individual assessment and is unsuitable in some circumstances. This article intentionally does not provide a pill-count schedule or instructions for self-prescribing. [1]
A recent possible exposure may need PEP instead
Seek PEP assessment as soon as possible and start when indicated within 72 hours. Do not wait for symptoms, all pending laboratory results or an online booking. Even after that window, seek assessment and a testing plan. Do not substitute or share PrEP yourself. [3]
Prevention choices do not determine moral worth
Do not infer the need for PrEP from identity, occupation or partner count alone. Discuss actual circumstances and preferences without stereotyping. U=U means a person on ART who maintains suppression meeting clinical criteria does not transmit HIV through sex; it is not a cure or a guarantee for breastfeeding or sharing injection equipment. [1] [4] [5]
Summary
PrEP is used by people without HIV before possible exposure. Being “on PrEP” is not the name of a separately approved medicine. Product choice depends on health, exposure route, preferences and local availability; this article is not a worldwide approval catalogue. [1]
ลิงก์และภาพประกอบเดิม
เก็บลิงก์เดิมไว้สำหรับการเข้าถึงข้อมูลประกอบ ไม่ใช้รับรองคำแนะนำทางการแพทย์ ราคา หรือเงื่อนไขปัจจุบัน
ลิงก์ประกอบเดิม 1 ลิงก์ประกอบเดิม 2 ลิงก์ประกอบเดิม 3 ลิงก์ประกอบเดิม 4
หมายเหตุ บทความนี้ให้ข้อมูลความรู้ทั่วไป ไม่ใช่การวินิจฉัย และไม่ใช่คำแนะนำการใช้ยาเฉพาะบุคคล เรื่องยาและการรักษาเป็นการตัดสินใจร่วมกับแพทย์หรือเภสัชกรที่ดูแลคุณ ไม่ควรซื้อ เริ่ม หยุด หรือปรับยาด้วยตัวเอง หากมีข้อสงสัยเกี่ยวกับสุขภาพของตัวเอง ปรึกษาเจ้าหน้าที่สาธารณสุขหรือคลินิกใกล้บ้านได้เสมอ
อ้างอิงตามข้อความที่ตรวจทาน
- CDC (สหรัฐฯ): การประเมินและติดตาม PrEP
- CDC (สหรัฐฯ): การตรวจ HIV และช่วงหน้าต่าง
- CDC (สหรัฐฯ): แนวทาง PEP ปี 2025
- NIH (สหรัฐฯ): U=U และการถ่ายทอดทางเพศสัมพันธ์
- กรมควบคุมโรค: การตีตราและเลือกปฏิบัติ ไม่ตัดสินหรือลดคุณค่าบุคคล
- CDC (สหรัฐฯ): การใช้ถุงยางและการจัดการเมื่อถุงยางแตก
- CDC (สหรัฐฯ): ช่องทางถ่ายทอด HIV
ตรวจทานและปรับปรุงเนื้อหา: 29 ตุลาคม 2569

